Alexandre J Vivanti, Camille Couffignal, Jeanne Sibiude, Anne-Gael Cordier, Vassilis Tsatsaris, Flore Rozenberg, Odile Launay, Alexandra Benachi, Daniele De Luca, Pierre-Yves Ancel, Estelle Marcault, Yves Ville, Julie Carrara, Dominique Luton, Marc Dommergues, Constance Borie, Gilles Kayem, Laurence Lecomte, Marianne Leruez-Ville, Claire Périllaud-Dubois, Valérie Biran, Pauline Manchon, Olivier Picone, Christelle Vauloup-Fellous
BACKGROUND: SARS-CoV-2 infection on pregnant women was the subject of many questions since the COVID-19 pandemic. METHODS: We aim to assess maternal and neonatal outcomes of SARS-CoV-2 infection contracted during 2nd and 3rd trimesters of pregnancy during the first two COVID-19 waves across a prospective French multicenter cohort study. Patients were included between April 2020 and January 2021 in 10 maternity hospitals in Paris area with two groups (i) pregnant women with a positive SARS-CoV-2 nasopharyngeal RT-PCR between [14WG; 37WG[(symptomatic infection), (ii) pregnant women with a negative serology (or equivocal) at delivery and without a positive SARS-CoV-2 nasopharyngeal RT-PCR at any time during pregnancy (G2 group) MAIN FINDINGS: 2410 pregnant women were included, of whom 310 had a positive SARS-CoV-2 nasopharyngeal RT-PCR and 217 between [14WG; 37WG[...
March 14, 2024: Journal of Gynecology Obstetrics and Human Reproduction